This Department of Veterans Affairs (VA) Notice updates the information on Tier 1 Medications.
FOR FURTHER INFORMATION CONTACT:
Tamara Wagner, Management Analyst, Office of Finance/Revenue Operations, Veterans Health Administration, (970) 242-0731, extension 2219.
SUPPLEMENTARY INFORMATION:
Section 17.110 of title 38, Code of Federal Regulations (CFR), governs copayments for medications that VA provides to veterans. Section 17.110 provides the methodologies for establishing the copayment amount for each 30-day or less supply of medication provided by VA on an outpatient basis (other than medication administered during treatment).
Tier 1 medication means a multi-source medication that has been identified using the process described in paragraph (b)(2) of § 17.110. Not less than once per year, VA will identify a subset of multi-source medications as Tier 1 medications. Only medications that meet all the criteria in 38 CFR 17.110(b)(2)(i), (ii), and (iii) will be eligible to be considered Tier 1 medications, and only those medications that meet all the criteria in paragraph (b)(2)(i) of this section will be assessed using the criteria in paragraphs (b)(2)(ii) and (iii).
Based on the methodologies set forth in § 17.110, this notice updates the list of Tier 1 medications for Calendar Year 2026. The Tier 1 medication list is posted on VA's website at the following link:
www.va.gov/resources/va-tier-1-copay-medication-list.
The following table is the Tier 1 Copay Medication List that is effective January 1, 2026, and will remain in effect until December 31, 2026.
Signing Authority:
Douglas A. Collins, Secretary of Veterans Affairs, approved this document on April 16, 2026, and authorized the undersigned to sign and submit the document to the Office of the Federal Register for publication electronically as an official document of the Department of Veterans Affairs.
Gabriela DeCuir,
Alternate Federal Register Liaison Officer, Department of Veterans Affairs.